The U.S. Patent and Trademark Office (USPTO) is set for a leadership change as President Donald Trump has nominated John Squires to serve as the next Director. Squires, a veteran intellectual property attorney with experience in both corporate and private practice, brings a background in patent law, financial technology, and... Read More

On February 28, 2025, the United States Patent and Trademark Office (USPTO) rescinded the June 21, 2022, memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation.” Issued under former USPTO Director Kathi Vidal, the memorandum significantly impacted the way the Patent Trial and... Read More

Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with Sandoz in the ongoing Caplyta (lumateperone) patent litigation. The announcement, which coincides with major industry developments, underscores ITCI's market position and strategic foresight. Settlement Details The litigation arose from Sandoz’s... Read More

Locke Lord and Troutman Pepper announced their merger back in September 2024, creating Troutman Pepper Locke LLP, a law firm with more than 1,600 attorneys across 33 offices in the United States and Europe. This merger effective January 1, 2025, marks the launch of a firm capable of delivering expanded services... Read More

Huawei Technologies has recently taken legal action against MediaTek, alleging patent infringement. The lawsuit, filed in a Chinese court, is part of Huawei's broader strategy to enhance revenue through licensing fees and royalties. MediaTek, a prominent supplier of application processors for smartphones and other consumer electronics, acknowledged the lawsuit but... Read More